Cholera and COVID-19 pandemic prevention in multiple hotspot districts of Uganda: vaccine coverage, adverse events following immunization and WASH conditions survey

[1]  D. Sack,et al.  Development of a Scorecard to Monitor Progress toward National Cholera Elimination: Its Application in Uganda , 2023, The American journal of tropical medicine and hygiene.

[2]  F. Mirzaie,et al.  Evaluation of Side Effects Associated with COVID-19 Vaccines in Pregnant Women , 2023, Medical Journal of The Islamic Republic of Iran.

[3]  L. Atuhaire,et al.  Factors Associated with COVID-19 Vaccine Hesitancy in Uganda: A Population-Based Cross-Sectional Survey , 2022, International journal of general medicine.

[4]  Wan Yang,et al.  COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant and implications for vaccination , 2022, Journal of the Royal Society Interface.

[5]  T. Cherian,et al.  Application of the Child Health and Nutrition Research Initiative (CHNRI) methodology to prioritize research to enable the implementation of Ending Cholera: A global roadmap to 2030 , 2022, PloS one.

[6]  S. Rubino,et al.  Alpha, Beta, Delta, Omicron, and SARS-CoV-2 Breakthrough Cases: Defining Immunological Mechanisms for Vaccine Waning and Vaccine-Variant Mismatch , 2022, Frontiers in Virology.

[7]  A. Talisuna,et al.  The COVID-19 pandemic in the African continent , 2022, BMC Medicine.

[8]  Dong Seok Lee,et al.  Adverse events following COVID-19 vaccination in South Korea between February 28 and August 21, 2021: A nationwide observational study , 2022, International Journal of Infectious Diseases.

[9]  D. Sack,et al.  An innovative approach in monitoring oral cholera vaccination campaign: integration of a between-round survey , 2022, BMC Public Health.

[10]  Mosoka P. Fallah,et al.  COVID-19 vaccine hesitancy in Africa: a call to action , 2021, The Lancet Global Health.

[11]  M. M. Hasan,et al.  Threats and outbreaks of cholera in Africa amidst COVID-19 pandemic: a double burden on Africa’s health systems , 2021, Tropical Medicine and Health.

[12]  Wan Yang,et al.  COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination. , 2021, medRxiv : the preprint server for health sciences.

[13]  E. Callaway.  Remember Beta? New data reveal variant's deadly toll. , 2021, Nature.

[14]  G. Reyes-Terán,et al.  Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine , 2021, Clinical Immunology.

[15]  C. Wiysonge,et al.  COVID-19 vaccine hesitancy in South Africa: A complex social phenomenon. , 2021, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[16]  Yunfeng Shang,et al.  Effects of Pandemic Outbreak on Economies: Evidence From Business History Context , 2021, Frontiers in Public Health.

[17]  J. Clemens,et al.  Licensed and Recommended Inactivated Oral CholeraVaccines: From Development to Innovative Deployment , 2021, Tropical medicine and infectious disease.

[18]  G. Boivin,et al.  Pandemics Throughout History , 2021, Frontiers in Microbiology.

[19]  D. Sack,et al.  Use of surveys to evaluate an integrated oral cholera vaccine campaign in response to a cholera outbreak in Hoima district, Uganda , 2020, BMJ Open.

[20]  Justin Wong,et al.  What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors , 2020, PloS one.

[21]  E. McBryde,et al.  Economic Consequences of the COVID-19 Outbreak: the Need for Epidemic Preparedness , 2020, Frontiers in Public Health.

[22]  Feng He,et al.  Coronavirus disease 2019: What we know? , 2020, Journal of medical virology.

[23]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[24]  L. Pezzoli.  Global oral cholera vaccine use, 2013-2018. , 2020, Vaccine.

[25]  J. Clemens,et al.  Epidemiology of cholera. , 2020, Vaccine.

[26]  F. Checchi,et al.  Prevention and control of cholera with household and community water, sanitation and hygiene (WASH) interventions: A scoping review of current international guidelines , 2020, PloS one.

[27]  T. D. Agusomu,et al.  Assessment of Water, Sanitation and Hygiene Services in Sub-Saharan Africa , 2018, European Scientific Journal ESJ.

[28]  B. Gessner,et al.  Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique , 2018, PloS one.

[29]  D. Legros.  Global Cholera Epidemiology: Opportunities to Reduce the Burden of Cholera by 2030 , 2018, The Journal of infectious diseases.

[30]  Goal 6: Ensure availability and sustainable management of water and sanitation for all , 2018, The Sustainable Development Goals Report 2018.

[31]  D. Sack,et al.  Identifying cholera "hotspots" in Uganda: An analysis of cholera surveillance data from 2011 to 2016 , 2017, PLoS neglected tropical diseases.

[32]  B. Gessner,et al.  Epidemiology of cholera outbreaks and socio-economic characteristics of the communities in the fishing villages of Uganda: 2011-2015 , 2017, PLoS neglected tropical diseases.

[33]  P. Reeves,et al.  Origins of the current seventh cholera pandemic , 2016, Proceedings of the National Academy of Sciences.

[34]  C. Orach,et al.  Cross-Border Cholera Outbreaks in Sub-Saharan Africa, the Mystery behind the Silent Illness: What Needs to Be Done? , 2016, PloS one.

[35]  E. Gotuzzo,et al.  The greatest steps towards the discovery of Vibrio cholerae. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[36]  Isaac Chun-Hai Fung,et al.  Cholera transmission dynamic models for public health practitioners , 2014, Emerging Themes in Epidemiology.

[37]  Young Eun Kim,et al.  The Burden of Cholera in Uganda , 2013, PLoS neglected tropical diseases.

[38]  D. Sack.  A new era in the history of cholera: the road to elimination. , 2013, International journal of epidemiology.

[39]  R. Grais,et al.  First Outbreak Response Using an Oral Cholera Vaccine in Africa: Vaccine Coverage, Acceptability and Surveillance of Adverse Events, Guinea, 2012 , 2013, PLoS neglected tropical diseases.

[40]  Allan Donner,et al.  Efficacy of a Low-Cost, Inactivated Whole-Cell Oral Cholera Vaccine: Results from 3 Years of Follow-Up of a Randomized, Controlled Trial , 2011, PLoS neglected tropical diseases.

[41]  A. Blenkinsop,et al.  World Health , 1957, Nature.

[42]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[43]  Melbourne Victoria,et al.  A Ministry of Health , 1917, Nature.

[44]  C. Macnamara.  On Cholera , 1868, The Indian medical gazette.

[45]  J. Snow.  On the Mode of Communication of Cholera , 1856, Edinburgh medical journal.

[46]  World Health Organization,et al.  Transmission of SARS-CoV-2: implications for infection prevention precautions , 2020 .

[47]  Cholera vaccines: WHO position paper – August 2017. , 2017, Releve epidemiologique hebdomadaire.

[48]  R. Henderson,et al.  Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. , 1982, Bulletin of the World Health Organization.